HEADER IMMUNE SYSTEM 15-JAN-10 3LEX TITLE 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN TITLE 2 COMPLEX WITH HIV-1 GP41 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 11F10 ANTIBODY HEAVY CHAIN; COMPND 3 CHAIN: H, A; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: 11F10 ANTIBODY LIGHT CHAIN; COMPND 6 CHAIN: L, B; COMPND 7 MOL_ID: 3; COMPND 8 MOLECULE: ENVELOPE GLYCOPROTEIN GP41; COMPND 9 CHAIN: P, C; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 STRAIN: BALB/C; SOURCE 6 CELL_LINE: MYELOMA CELL LINE FO; SOURCE 7 CELL: HYBRIDOMA; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 10 ORGANISM_COMMON: MOUSE; SOURCE 11 ORGANISM_TAXID: 10090; SOURCE 12 STRAIN: BALB/C; SOURCE 13 CELL_LINE: MYELOMA CELL LINE FO; SOURCE 14 CELL: HYBRIDOMA; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 18 ORGANISM_TAXID: 11676; SOURCE 19 OTHER_DETAILS: HIV-1 GP41 PEPTIDE KEYWDS HIV-1, GP-41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, KEYWDS 2 TRANSPLANT, GRAFT, RE-ELCITATION, ENVELOPE PROTEIN, IMMUNE SYSTEM, KEYWDS 3 VACCINE DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR G.OFEK,F.J.GUENAGA,W.R.SCHIEF,J.SKINNER,D.BAKER,R.WYATT,P.D.KWONG REVDAT 4 09-OCT-24 3LEX 1 REMARK REVDAT 3 06-SEP-23 3LEX 1 DBREF SHEET REVDAT 2 24-NOV-10 3LEX 1 JRNL REVDAT 1 29-SEP-10 3LEX 0 JRNL AUTH G.OFEK,F.J.GUENAGA,W.R.SCHIEF,J.SKINNER,D.BAKER,R.WYATT, JRNL AUTH 2 P.D.KWONG JRNL TITL ELICITATION OF STRUCTURE-SPECIFIC ANTIBODIES BY EPITOPE JRNL TITL 2 SCAFFOLDS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 107 17880 2010 JRNL REFN ISSN 0027-8424 JRNL PMID 20876137 JRNL DOI 10.1073/PNAS.1004728107 REMARK 2 REMARK 2 RESOLUTION. 1.97 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.90 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.060 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.4 REMARK 3 NUMBER OF REFLECTIONS : 49480 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1992 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 25.9030 - 4.7270 0.91 3303 152 0.1670 0.1540 REMARK 3 2 4.7270 - 3.7560 0.92 3327 145 0.1340 0.1470 REMARK 3 3 3.7560 - 3.2820 0.92 3362 139 0.1450 0.1650 REMARK 3 4 3.2820 - 2.9820 0.93 3399 140 0.1620 0.1900 REMARK 3 5 2.9820 - 2.7690 0.95 3413 147 0.1730 0.2220 REMARK 3 6 2.7690 - 2.6060 0.94 3414 140 0.1800 0.2070 REMARK 3 7 2.6060 - 2.4750 0.95 3433 145 0.1770 0.2560 REMARK 3 8 2.4750 - 2.3680 0.95 3486 147 0.1840 0.2380 REMARK 3 9 2.3680 - 2.2770 0.95 3473 146 0.1810 0.2250 REMARK 3 10 2.2770 - 2.1980 0.95 3429 135 0.1830 0.2520 REMARK 3 11 2.1980 - 2.1290 0.95 3434 142 0.1660 0.2470 REMARK 3 12 2.1290 - 2.0690 0.94 3416 145 0.1760 0.2250 REMARK 3 13 2.0690 - 2.0140 0.94 3431 143 0.1730 0.2350 REMARK 3 14 2.0140 - 1.9650 0.86 3168 126 0.1850 0.2490 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 50.85 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 1.160 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.46 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.48600 REMARK 3 B22 (A**2) : -10.32100 REMARK 3 B33 (A**2) : -1.16500 REMARK 3 B12 (A**2) : 1.45700 REMARK 3 B13 (A**2) : -2.51200 REMARK 3 B23 (A**2) : 0.63100 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 6967 REMARK 3 ANGLE : 0.892 9496 REMARK 3 CHIRALITY : 0.060 1074 REMARK 3 PLANARITY : 0.005 1195 REMARK 3 DIHEDRAL : 14.174 2419 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3LEX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-FEB-10. REMARK 100 THE DEPOSITION ID IS D_1000057192. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-APR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : SI (220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49925 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.960 REMARK 200 RESOLUTION RANGE LOW (A) : 25.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 5.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03800 REMARK 200 FOR THE DATA SET : 33.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.97 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.04 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.09200 REMARK 200 FOR SHELL : 12.90 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3LEY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG 4000, 0.08 M CH3COONA, 0.04 M, REMARK 280 TRIS PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS H 127 REMARK 465 GLY H 128 REMARK 465 ASP H 129 REMARK 465 THR H 130 REMARK 465 THR H 131 REMARK 465 PRO H 214 REMARK 465 THR H 215 REMARK 465 ILE H 216 REMARK 465 LYS H 217 REMARK 465 CYS A 127 REMARK 465 GLY A 128 REMARK 465 ASP A 129 REMARK 465 THR A 130 REMARK 465 THR A 131 REMARK 465 PRO A 214 REMARK 465 THR A 215 REMARK 465 ILE A 216 REMARK 465 LYS A 217 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU P 660 N CA CB CG CD1 CD2 REMARK 470 LEU C 660 N CA CB CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 6 NE2 GLN A 104 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH2 ARG L 82 O GLY A 213 1655 2.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER H 15 -17.85 80.65 REMARK 500 TYR H 33 165.92 83.59 REMARK 500 ASN H 43 4.11 83.35 REMARK 500 ASP H 172 19.34 56.87 REMARK 500 VAL L 56 -44.67 74.29 REMARK 500 LEU L 186 -168.68 -119.64 REMARK 500 ASN L 217 27.62 -76.66 REMARK 500 SER A 15 -19.86 79.78 REMARK 500 TYR A 33 166.42 82.60 REMARK 500 ASN A 43 5.12 80.61 REMARK 500 SER A 171 50.76 80.95 REMARK 500 ASP A 172 16.06 59.83 REMARK 500 VAL B 51 -45.29 73.75 REMARK 500 SER B 52 -1.35 -141.12 REMARK 500 LEU B 181 -166.77 -118.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3LES RELATED DB: PDB REMARK 900 2F5 EPITOPE SCAFFOLD ES2 REMARK 900 RELATED ID: 3LEV RELATED DB: PDB REMARK 900 HIV-1 ANTIBODY 2F5 IN COMPLEX WITH EPITOPE SCAFFOLD ES2 REMARK 900 RELATED ID: 3LEY RELATED DB: PDB REMARK 900 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 6A7 IN REMARK 900 COMPLEX WITH HIV-1 GP41 REMARK 900 RELATED ID: 1TJI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY REMARK 900 2F5 IN COMPLEX WITH A GP41 17MER DBREF 3LEX H 1 217 PDB 3LEX 3LEX 1 217 DBREF 3LEX L 1 219 PDB 3LEX 3LEX 1 219 DBREF 3LEX P 660 668 UNP Q9IJQ0 Q9IJQ0_9HIV1 100 108 DBREF 3LEX A 1 217 PDB 3LEX 3LEX 1 217 DBREF 3LEX B 1 214 PDB 3LEX 3LEX 1 214 DBREF 3LEX C 660 668 UNP Q9IJQ0 Q9IJQ0_9HIV1 100 108 SEQRES 1 H 221 ASP VAL GLN LEU GLN GLU SER GLY PRO GLY LEU VAL LYS SEQRES 2 H 221 PRO SER GLN SER LEU SER LEU THR CYS THR VAL THR GLY SEQRES 3 H 221 TYR SER ILE THR SER ASP TYR ALA TRP SER TRP ILE ARG SEQRES 4 H 221 GLN PHE PRO GLY ASN LYS LEU GLU TRP MET GLY TYR ILE SEQRES 5 H 221 ASN TYR SER GLY TYR THR SER TYR ASN PRO SER LEU LYS SEQRES 6 H 221 SER ARG ILE SER ILE THR ARG ASP THR SER GLU ASN GLN SEQRES 7 H 221 PHE PHE LEU GLN LEU HIS SER VAL THR PRO GLU ASP THR SEQRES 8 H 221 ALA THR TYR PHE CYS ALA TYR GLY ASN TYR LEU PRO ALA SEQRES 9 H 221 TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER ALA ALA SEQRES 10 H 221 LYS THR THR ALA PRO SER VAL TYR PRO LEU ALA PRO VAL SEQRES 11 H 221 CYS GLY ASP THR THR GLY SER SER VAL THR LEU GLY CYS SEQRES 12 H 221 LEU VAL LYS GLY TYR PHE PRO GLU PRO VAL THR LEU THR SEQRES 13 H 221 TRP ASN SER GLY SER LEU SER SER GLY VAL HIS THR PHE SEQRES 14 H 221 PRO ALA VAL LEU GLN SER ASP LEU TYR THR LEU SER SER SEQRES 15 H 221 SER VAL THR VAL THR SER SER THR TRP PRO SER GLN SER SEQRES 16 H 221 ILE THR CYS ASN VAL ALA HIS PRO ALA SER SER THR LYS SEQRES 17 H 221 VAL ASP LYS LYS ILE GLU PRO ARG GLY PRO THR ILE LYS SEQRES 1 L 219 ASP VAL VAL MET THR GLN THR PRO LEU SER LEU SER VAL SEQRES 2 L 219 THR ILE GLY GLN PRO ALA SER ILE SER CYS LYS SER SER SEQRES 3 L 219 GLN SER LEU LEU ASP SER ASP GLY LYS THR TYR LEU ASN SEQRES 4 L 219 TRP LEU LEU GLN ARG PRO GLY GLN SER PRO LYS ARG LEU SEQRES 5 L 219 ILE TYR LEU VAL SER LYS LEU ALA SER GLY VAL PRO ASP SEQRES 6 L 219 ARG PHE THR GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 219 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 L 219 TYR CYS TRP GLN GLY THR HIS PHE PRO TRP THR PHE GLY SEQRES 9 L 219 GLY TYR THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA SEQRES 10 L 219 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 L 219 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 L 219 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 L 219 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 L 219 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 L 219 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 L 219 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 L 219 PRO ILE VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 P 9 LEU LEU GLU LEU ASP LYS TRP ALA NH2 SEQRES 1 A 221 ASP VAL GLN LEU GLN GLU SER GLY PRO GLY LEU VAL LYS SEQRES 2 A 221 PRO SER GLN SER LEU SER LEU THR CYS THR VAL THR GLY SEQRES 3 A 221 TYR SER ILE THR SER ASP TYR ALA TRP SER TRP ILE ARG SEQRES 4 A 221 GLN PHE PRO GLY ASN LYS LEU GLU TRP MET GLY TYR ILE SEQRES 5 A 221 ASN TYR SER GLY TYR THR SER TYR ASN PRO SER LEU LYS SEQRES 6 A 221 SER ARG ILE SER ILE THR ARG ASP THR SER GLU ASN GLN SEQRES 7 A 221 PHE PHE LEU GLN LEU HIS SER VAL THR PRO GLU ASP THR SEQRES 8 A 221 ALA THR TYR PHE CYS ALA TYR GLY ASN TYR LEU PRO ALA SEQRES 9 A 221 TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER ALA ALA SEQRES 10 A 221 LYS THR THR ALA PRO SER VAL TYR PRO LEU ALA PRO VAL SEQRES 11 A 221 CYS GLY ASP THR THR GLY SER SER VAL THR LEU GLY CYS SEQRES 12 A 221 LEU VAL LYS GLY TYR PHE PRO GLU PRO VAL THR LEU THR SEQRES 13 A 221 TRP ASN SER GLY SER LEU SER SER GLY VAL HIS THR PHE SEQRES 14 A 221 PRO ALA VAL LEU GLN SER ASP LEU TYR THR LEU SER SER SEQRES 15 A 221 SER VAL THR VAL THR SER SER THR TRP PRO SER GLN SER SEQRES 16 A 221 ILE THR CYS ASN VAL ALA HIS PRO ALA SER SER THR LYS SEQRES 17 A 221 VAL ASP LYS LYS ILE GLU PRO ARG GLY PRO THR ILE LYS SEQRES 1 B 219 ASP VAL VAL MET THR GLN THR PRO LEU SER LEU SER VAL SEQRES 2 B 219 THR ILE GLY GLN PRO ALA SER ILE SER CYS LYS SER SER SEQRES 3 B 219 GLN SER LEU LEU ASP SER ASP GLY LYS THR TYR LEU ASN SEQRES 4 B 219 TRP LEU LEU GLN ARG PRO GLY GLN SER PRO LYS ARG LEU SEQRES 5 B 219 ILE TYR LEU VAL SER LYS LEU ALA SER GLY VAL PRO ASP SEQRES 6 B 219 ARG PHE THR GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 B 219 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 B 219 TYR CYS TRP GLN GLY THR HIS PHE PRO TRP THR PHE GLY SEQRES 9 B 219 GLY TYR THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA SEQRES 10 B 219 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 B 219 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 B 219 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 B 219 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 B 219 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 B 219 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 B 219 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 B 219 PRO ILE VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 C 9 LEU LEU GLU LEU ASP LYS TRP ALA NH2 HET NH2 P 668 1 HET NH2 C 668 1 HETNAM NH2 AMINO GROUP FORMUL 3 NH2 2(H2 N) FORMUL 7 HOH *628(H2 O) HELIX 1 5 GLU L 84 LEU L 88 5 5 HELIX 2 6 SER L 126 SER L 132 1 7 HELIX 3 7 LYS L 188 GLU L 192 1 5 HELIX 4 8 ASN L 217 CYS L 219 5 3 HELIX 5 9 LEU A 63 SER A 65 5 3 HELIX 6 10 THR A 83 THR A 87 5 5 HELIX 7 11 PRO A 199 SER A 202 5 4 HELIX 8 12 GLU B 79 LEU B 83 5 5 HELIX 9 13 SER B 121 SER B 127 1 7 HELIX 10 14 LYS B 183 GLU B 187 1 5 SHEET 1 A 2 GLN H 3 SER H 7 0 SHEET 2 A 2 LEU H 18 THR H 25 -1 O THR H 21 N SER H 7 SHEET 1 B 1 LEU H 11 VAL H 12 0 SHEET 1 C 1 LEU H 11 VAL H 12 0 SHEET 1 G 2 MET L 4 THR L 7 0 SHEET 2 G 2 ALA L 19 SER L 25 -1 O SER L 22 N THR L 7 SHEET 1 H 1 SER L 10 VAL L 13 0 SHEET 1 I 1 SER L 10 VAL L 13 0 SHEET 1 L 2 GLN A 3 SER A 7 0 SHEET 2 L 2 LEU A 18 THR A 25 -1 O THR A 21 N SER A 7 SHEET 1 M 1 LEU A 11 VAL A 12 0 SHEET 1 N 1 LEU A 11 VAL A 12 0 SHEET 1 R 2 MET B 4 THR B 7 0 SHEET 2 R 2 ALA B 19 SER B 25 -1 O LYS B 24 N THR B 5 SHEET 1 S 1 SER B 10 VAL B 13 0 SHEET 1 T 1 SER B 10 VAL B 13 0 SSBOND 1 CYS H 22 CYS H 92 1555 1555 2.06 SSBOND 2 CYS H 139 CYS H 194 1555 1555 2.04 SSBOND 3 CYS L 23 CYS L 93 1555 1555 2.04 SSBOND 4 CYS L 139 CYS L 199 1555 1555 2.04 SSBOND 5 CYS A 22 CYS A 92 1555 1555 2.06 SSBOND 6 CYS A 139 CYS A 194 1555 1555 2.04 SSBOND 7 CYS B 23 CYS B 88 1555 1555 2.04 SSBOND 8 CYS B 134 CYS B 194 1555 1555 2.04 CISPEP 1 ASN H 96 TYR H 97 0 2.64 CISPEP 2 PHE H 145 PRO H 146 0 -3.59 CISPEP 3 GLU H 147 PRO H 148 0 3.25 CISPEP 4 TRP H 187 PRO H 188 0 3.61 CISPEP 5 THR L 7 PRO L 8 0 -1.62 CISPEP 6 PHE L 99 PRO L 100 0 1.49 CISPEP 7 TYR L 145 PRO L 146 0 3.03 CISPEP 8 ASN A 96 TYR A 97 0 3.28 CISPEP 9 PHE A 145 PRO A 146 0 -3.01 CISPEP 10 GLU A 147 PRO A 148 0 1.70 CISPEP 11 TRP A 187 PRO A 188 0 5.05 CISPEP 12 THR B 7 PRO B 8 0 1.47 CISPEP 13 PHE B 94 PRO B 95 0 -0.11 CISPEP 14 TYR B 140 PRO B 141 0 1.58 CRYST1 34.543 70.962 78.265 90.08 90.02 90.29 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028949 0.000147 0.000010 0.00000 SCALE2 0.000000 0.014092 0.000020 0.00000 SCALE3 0.000000 0.000000 0.012777 0.00000